Clinical Trial

Concussion Treatment in Older Adults

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.
Protocol Amendment History 2 changes
critical Trial completed 2026-08-07
notable Enrollment increased: 50 -> 56 participants 2026-08-07
Trial Details
NCT Number NCT05849064
Lead Sponsor University of Pittsburgh
Conditions Concussion, Mild
Enrollment 56 participants
Start Date 2023-09-07
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-06